Targeting EGFR of triple-negative breast cancer enhances the therapeutic efficacy of paclitaxel- and cetuximab-conjugated nanodiamond nanocomposite

Wei Siang Liao, Yu Ho, Yu Wei Lin, Emmanuel Naveen Raj, Kuang Kai Liu, Chinpiao Chen, Xiao Zhen Zhou, Kun Ping Lu, Jui-I Chao*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

28 Scopus citations

Fingerprint Dive into the research topics of 'Targeting EGFR of triple-negative breast cancer enhances the therapeutic efficacy of paclitaxel- and cetuximab-conjugated nanodiamond nanocomposite'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds

Engineering & Materials Science